Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome.

Abstract

CONTEXT:

Distinguishing between pituitary [Cushing's disease (CD)] and ectopic causes [ectopic ACTH syndrome (EAS)] of ACTH-dependent Cushing's syndrome can be challenging. Inferior petrosal sinus sampling (IPSS) best discriminates between CD and occult EAS but is a specialized procedure that is not widely available. Identifying adjunctive diagnostic tests may prove useful. In EAS, abnormal processing of the ACTH precursor proopiomelanocortin (POMC) and the accumulation of POMC-derived peptides might be expected and abnormal levels of other neuropeptides may be detected.

OBJECTIVE:

The objective of the study was to evaluate the diagnostic utility of POMC measurements for distinguishing between CD and occult EAS in patients referred for IPSS. Another objective of the study was to evaluate in parallel the diagnostic utility of another neuropeptide, agouti-related protein (AgRP), because we have observed a 10-fold elevation of AgRP in plasma in a patient with EAS from small-cell lung cancer.

DESIGN AND PARTICIPANTS:

Plasma POMC and AgRP were measured in 38 Cushing's syndrome patients presenting for IPSS, with either no pituitary lesion or a microadenoma on magnetic resonance imaging, and in 38 healthy controls.

RESULTS:

Twenty-seven of 38 patients had CD; 11 of 38 had EAS. The mean POMC was higher in EAS vs CD [54.5 ± 13.0 (SEM) vs 17.2 ± 1.5 fmol/mL; P < .05]. Mean AgRP was higher in EAS vs CD (280 ± 76 vs 120 ± 16 pg/mL; P = .01). Although there was an overlap in POMC and AgRP levels between the groups, the POMC levels greater than 36 fmol/mL (n = 7) and AgRP levels greater than 280 pg/mL (n = 3) were specific for EAS. When used together, POMC greater than 36 fmol/mL and/or AgRP greater than 280 pg/mL detected 9 of 11 cases of EAS, indicating that elevations in these peptides have a high positive predictive value for occult EAS.

CONCLUSIONS:

Expanding upon previous observations of high POMC in EAS, this study specifically demonstrates elevated POMC levels can identify occult ectopic tumors. Elevations in AgRP also favor the diagnosis of EAS, suggesting AgRP should be further evaluated as a potential neuroendocrine tumor marker.

• Authors: Gabrielle Page-Wilson, Pamela U Freda, Thomas P Jacobs, Alexander G Khandji, Jeffrey N Bruce, Sandra T Foo, Kana Meece, Anne White, Sharon L Wardlaw
• Journal: The Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 99 Issue 10 Pg. E1838-45 (Oct 2014) ISSN: 1945-7197 [Electronic] United States
• PMID: 25013995 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• AGRP protein, human
• Agouti-Related Protein
• Biomarkers
• Pro-Opiomelanocortin
• Adrenocorticotropic Hormone

Topics

• ACTH Syndrome, Ectopic (blood, diagnosis, pathology)
• Adrenal Gland Neoplasms (blood, pathology)
• Adrenocorticotropic Hormone (blood)
• Adult
• Agouti-Related Protein (blood)
• Biomarkers (blood)
• Cushing Syndrome (blood, diagnosis, pathology)
• Diagnosis, Differential
• Female
• Humans
• Lung Neoplasms (blood, secondary)
• Magnetic Resonance Imaging
• Male
• Middle Aged
• Neuroendocrine Tumors (blood, pathology)
• Petrosal Sinus Sampling
• Pro-Opiomelanocortin (blood)
• Sensitivity and Specificity
• Small Cell Lung Carcinoma (blood, secondary)